Association of CD8+ T lymphocyte repertoire spreading with the severity of DRESS syndrome

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Niu, Jun ^a   Jia, Qingzhu ^a,b   Ni, Qingshan ^a,b   Yang, Yi ^a,b   Chen, Gang ^a,b   Yang, Xichuan ^a   Zhai, Zhifang ^a   Yu, Haili ^a,b   Guan, Peng ^a,b   Lin, Regina ^c   Song, Zhiqiang ^a   Li, Qi Jing ^b,c   Hao, Fei ^a   Zhong, Hua ^a   Wan, Ying ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Chongqing Key Laboratory of Cytomics   (China)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; VIRUS ANTIBODY;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMISTRY; CLUSTER ANALYSIS; DNA SEQUENCE; DRESS SYNDROME; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; SEVERITY OF ILLNESS INDEX; T LYMPHOCYTE SUBPOPULATION;

ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLUSTER ANALYSIS; DRUG HYPERSENSITIVITY SYNDROME; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANTIGEN, T-CELL; SEQUENCE ANALYSIS, DNA; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTE SUBSETS;

EID: 84928532251     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09913     Document Type: Article

References (31)

1. Hunziker, T., Kunzi, U. P., Braunschweig, S., Zehnder, D. & Hoigne, R. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 52, 388-393. (1997).
2. Chen, Y. C., Chang, C. Y., Cho, Y. T., Chiu, H. C. & Chu, C. Y. Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan. J. Am. Acad. Dermatol. 68, 459-465. doi: 410.1016/j.jaad.2012.1008.1009. Epub 2012 Sep 1016. (2013).
3. Hertl, M., Jugert, F. & Merk, H. F. CD8+ dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes. Br. J. Dermatol. 132, 215-220. (1995).
4. Depta, J. P. et al. Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity. J. Allergy Clin. Immunol. 113, 519-527. (2004).
5. Picard, D. et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci. Transl. Med. 2, 46ra62. doi: 10.1126/scitranslmed.3001116. (2010).
6. Arstila, T. P. et al. A direct estimate of the human alphabeta T cell receptor diversity. Science 286, 958-961 (1999).
7. Benichou, J., Ben-Hamo, R., Louzoun, Y. & Efroni, S. Rep-Seq: uncovering the immunological repertoire through next-generation sequencing. Immunology 135, 183-191, doi:10.1111/j.1365-2567.2011.03527.x (2012).
8. Morris, H. et al. Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients. Science translational medicine 7, 272ra210, doi:10.1126/scitranslmed.3010760 (2015).
9. Venturi, V. et al. Method for assessing the similarity between subsets of the T cell receptor repertoire. J. Immunol. Methods 329, 67-80, doi:10.1016/j.jim.2007.09.016 (2008).
10. Shiohara, T., Inaoka, M. & Kano, Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol. Int. 55, 1-8. (2006).
11. Vanderlugt, C. L. & Miller, S. D. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2, 85-95. (2002).
12. Lehmann, P. V., Forsthuber, T., Miller, A. & Sercarz, E. E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358, 155-157. (1992).
13. Yu, M., Johnson, J. M. & Tuohy, V. K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183, 1777-1788. (1996).
14. Yu, M., Kinkel, R. P., Weinstock-Guttman, B., Cook, D. J. & Tuohy, V. K. HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis. Hum. Immunol. 59, 15-24. (1998).
15. Miller, S. D. et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3, 1133-1136. (1997).
16. Hirahara, K. et al. Differences in immunological alterations and underlying viral infections in two well-defined severe drug eruptions. Clin. Exp. Dermatol. 35, 863-868. doi: 810.1111/j.1365-2230.2010.03820.x. (2010).
17. Takahashi, R. et al. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J. Immunol. 182, 8071-8079. doi: 8010.4049/jimmunol.0804002. (2009).
18. Teague, R. M. et al. Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor. Immunity 28, 662-674. doi: 610.1016/j.immuni.2008.1003.1012. (2008).
19. Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. & Heath, W. R. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J. Exp. Med. 186, 239-245. (1997).
20. Le Campion, A. et al. Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development. Blood 114, 1784-1793. doi: 1710.1182/blood-2008-1712-192120. Epub 192009 Jun 192126. (2009).
21. Cha, E. et al. Improved Survival with T Cell Clonotype Stability After Anti-CTLA-4 Treatment in Cancer Patients. Sci. Transl. Med. 6, 238ra270. doi: 210.1126/scitranslmed.3008211. (2014).
22. Galvao, V. R., Aun, M. V., Kalil, J., Castells, M. & Giavina-Bianchi, P. Clinical and laboratory improvement after intravenous immunoglobulin in drug reaction with eosinophilia and systemic symptoms. J. Allergy Clin. Immunol. Pract. 2, 107-110. doi: 110.1016/j.jaip.2013.1011.1008. (2014).
23. Moling, O. et al. Treatment of DIHS/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir - a hypothesis. Med. Sci. Monit. 18, CS57-62. (2012).
24. Shiohara, T. & Kano, Y. A complex interaction between drug allergy and viral infection. Clin. Rev. Allergy Immunol. 33, 124-133. (2007).
25. Criado, P. R. et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system. Isr. Med. Assoc. J. 14, 577-582. (2012).
26. Bocquet, H., Bagot, M. & Roujeau, J. C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin. Cutan. Med. Surg. 15, 250-257. (1996).
27. Husain, Z., Reddy, B. Y. & Schwartz, R. A. DRESS syndrome: Part II. Management and therapeutics. J. Am. Acad. Dermatol. 68, 709.e701-709; quiz 718-720. doi: 710.1016/j.jaad.2013.1001.1032. (2013).
28. Karnofsky, D. A. Summary of results obtained with nitrogen mustard in the treatment of neoplastic disease. Ann. N. Y. Acad. Sci. 68, 899-914. (1958).
29. Kardaun, S. H. et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br. J. Dermatol. 156, 609-611. (2007).
30. Giudicelli, V. et al. IMGT/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucleic acids research 34, D781-784, doi:10.1093/nar/gkj088 (2006).
31. Rempala, G. A. & Seweryn, M. Methods for diversity and overlap analysis in T-cell receptor populations. Journal of mathematical biology 67, 1339-1368, doi:10.1007/s00285-012-0589-7 (2013).